Correlation Between Eterna Therapeutics and Dr Reddys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Dr Reddys Laboratories, you can compare the effects of market volatilities on Eterna Therapeutics and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Dr Reddys.

Diversification Opportunities for Eterna Therapeutics and Dr Reddys

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Eterna and RDY is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Dr Reddys go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Dr Reddys

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Dr Reddys. In addition to that, Eterna Therapeutics is 7.67 times more volatile than Dr Reddys Laboratories. It trades about -0.06 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about -0.03 per unit of volatility. If you would invest  1,410  in Dr Reddys Laboratories on November 18, 2024 and sell it today you would lose (50.00) from holding Dr Reddys Laboratories or give up 3.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eterna Therapeutics  vs.  Dr Reddys Laboratories

 Performance 
       Timeline  
Eterna Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Dr Reddys Laboratories 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eterna Therapeutics and Dr Reddys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eterna Therapeutics and Dr Reddys

The main advantage of trading using opposite Eterna Therapeutics and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.
The idea behind Eterna Therapeutics and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins